Medolife Rx Presents Its Venom-To-Drug Development Projects at an International Conference Held in the Dominican Republic

January 11, 2022

Caleb DesRosiers, JD, MPA Appointed to Daxor Corporation Board of Directors

January 21, 2022
22nd Century Group Appoints James A. Mish to Its Board of Directors

January 21, 2022
Daxor Corporation to Commence Trading on The Nasdaq Capital Market On February 2, 2022

January 20, 2022
Alkaline88® Leads Fourth Quarter Growth for Enhanced Water Brands

January 19, 2022